Trade Mark Journal No.2025/043 24 October 2025
WO0000001880408 (5,10,45)
Office of origin: United States of America
Date of International Registration:11 September 2025
Date of designation in the UK:
11 September 2025

International priority date claimed: 9 September 2025
(United States of America)
(99382166)
- Class 5
- Pharmaceutical products for the treatment of cancer; drug delivery systems, namely, drug delivery agents consisting of compounds that facilitate delivery of a range of pharmaceuticals; pharmaceutical preparations, namely, drug delivery systems comprising melphalan hydrochloride for injection for administering high dose chemotherapy to the liver.
- Class 10
- Drug delivery systems; double balloon catheter system comprised primarily of catheters.
- Class 45
- Providing personal support services for patients and families of patients with liver disorders, namely, financial counseling, help with medical forms and care coordination.
Delcath Systems, Inc.
Representative: Deborah J. Peckham Barclay Damon LLP, 160 Federal Street, Suite 1001, Boston MA 02110, UNITED STATES OF AMERICA